Close Menu

NEW YORK — Chinese molecular diagnostics firm Burning Rock said on Monday that the underwriters of its recent US initial public offering have exercised their overallotment option, giving the transaction a value of roughly $256.2 million.

Burning Rock also said that investment group Lake Bleu Prime Healthcare Master Fund has purchased a $25 million equity stake in the company. Taken together, the two transactions have raised about $281.2 million for Burning Rock.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.